tm
Seeing Is Believing
tm
Seeing Is Believing
Sonnet Biotherapeutics Holdings's activity chart (see below) currently has 4 price targets and 18 ratings on display.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 07-Apr-2025. First documented stock forecast 05-Jun-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jun-2020
1 years 5 months 26 days ago
(07-Apr-2025)
0/2 (0%)
$5102.27 (444.55%)
Buy Since 17-Dec-2021
3 years 1 months 10 days ago
(23-Aug-2023)
0/1 (0%)
$3769.92 (325.53%)
Buy Since 15-Sep-2021
$12142598
$12142597 (100000000.00%)
$30356496
4 years 7 months 24 days ago
(09-Feb-2022)
0/2 (0%)
$12141837 (1594714.50%)
Which analyst most recently updated their price target on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst has the most public recommendations on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most bullish on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most reserved on SONN (Sonnet Biotherapeutics Holdings)?
